Evidence map›Paper›PMID 40237002›Full record

ArticleIDCases2025

An autochthonous case of severe

Paul Dalmas, Elsa Kaphan, Coline Mortier, Margaux Froidefond, Barbara Doudier, Laeticia Ninove, Antoine Nougairede, Guillaume André Durand, Jean-Christophe Lagier, Nadim Cassir

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul DalmasIHU Méditerranée Infection, AP-HM, Marseille, France.
Elsa KaphanDivision of Internal Medicine and Clinical Immunology, Hôpital Conception, APHM, Marseille, France.
Coline MortierIHU Méditerranée Infection, AP-HM, Marseille, France.
Margaux FroidefondIHU Méditerranée Infection, AP-HM, Marseille, France.
Barbara DoudierIHU Méditerranée Infection, AP-HM, Marseille, France.
Laeticia NinoveUnité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.
Antoine NougairedeUnité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.
Guillaume André DurandNational Reference Center for Arboviruses, Inserm-IRBA, Marseille, France.
Jean-Christophe LagierIHU Méditerranée Infection, AP-HM, Marseille, France.
Nadim CassirIHU Méditerranée Infection, AP-HM, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tick-borne encephalitis virus (TBEV) is a common cause of viral encephalitis in parts of Central and Eastern Europe, with a recent resurgence of cases and geographical expansion. Active immunization results in a high rate of seroconversion and is the most effective measure to reduce the incidence of tick-borne encephalitis (TBE). In France, an endemic country, vaccination is recommended only for travelers staying in rural or forested areas in endemic regions. Polyvalent intravenous immunoglobulin (IVIG) is sometimes used as rescue treatment of viral encephalitis. However, few cases of TBEV meningoencephalitis treated with polyvalent IVIG have been described. We report here a case of autochthonous TBEV meningoencephalitis in a French patient with cranial nerve involvement that was treated with IVIG and discuss the possible mechanisms of action.

Indexed as

Intravenous immunoglobulinsTick-borne encephalitisTick-borne encephalitis virus

Identifiers

PMID40237002
PMCPMC11999177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.